Global Enzymes Market Projected to Grow at 14% CAGR, Reaching $25.88 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Enzymes Market Through 2025?
The size of the enzymes market has experienced brisk expansion over the past few years. It is projected to grow from $13.38 billion in 2024 to about $15.33 billion in 2025, showcasing a compound annual growth rate (CAGR) of 14.6%. This progression in the historical period is primarily due to factors such as globalization, expansion of the market, increased investments in research and development, heightened consumer awareness and demand, advancements in bioprocessing technology, and efforts towards waste reduction and recycling.

What's the Projected Size of the Global Enzymes Market by 2029?
Anticipated to experience a swift expansion in the forthcoming years, the enzymes market size is projected to reach $25.88 billion in 2029, boasting a Compound Annual Growth Rate (CAGR) of 14.0%. The predicted growth during the forecast period is credited to factors such as market demand dynamics, an emphasis on sustainable practices, trends in health and nutrition, biofuel and renewable energy, and emerging applications. It's also important to note that during the forecast period, significant trends will encompass advancements in biotechnology, increasing demand for sustainability, a surge in food and beverage industry demands, the growth of industrial applications, and a shift in consumer preferences towards natural products.

View the full report here:
https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

Top Growth Drivers in the Enzymes Industry: What's Accelerating the Market?
The increasing occurrence of digestive maladies is anticipated to fuel the expansion of the enzyme market in the coming years. Digestive maladies encompass various health issues that impact the digestive system, such as gastroesophageal reflux disease (GERD), cancer, irritable bowel syndrome (IBS), lactose intolerance, hiatal hernia, and gallstones. Digestive enzymes assist in decomposing food into more manageable molecules for the body to absorb. For example, in the month of October 2022, the National Center for Biotechnology Information (NCBI), a scientific research resource based in the U.S., disclosed that the prevalence of irritable bowel syndrome (IBS) is around 10 - 15% in the United States, with roughly 12% of patients consulting primary health care practices due to IBS-related issues. Therefore, the escalating prevalence of digestive problems is a crucial factor propelling the enzyme market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3425&type=smp

What Trends Will Shape the Enzymes Market Through 2029 and Beyond?
Leading firms in the enzyme market, such as Chiesi Global Rare Diseases, are pushing the boundaries of their offerings with innovative products like Lamzede designed to better serve patients. Lamzede (velmanase alfa) is a distinct therapeutic used for alpha-mannosidosis, a rare genetic disorder caused by the deficiency of lysosomal alpha-galactosidase-A enzyme. Specifically, in May 2023, Chiesi Global Rare Diseases, an American pharmaceutical production company, secured FDA approval for the use of Lamzede (velmanase alfa) to treat non-neurological symptoms in individuals suffering from mild-to-moderate alpha-mannosidosis. Produced using recombinant DNA technology in Chinese hamster ovary* (CHO) cells, Lamzede is a recombinant variant of human alpha-mannosidase. It holds the distinction of being the first enzyme replacement therapy sanctioned in the U.S. for addressing the non-central nervous system manifestations of alpha-mannosidosis.

What Are the Main Segments in the Enzymes Market?
The enzymes market covered in this report is segmented -

1) By Product Type: Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products
2) By Application: Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications
3) By End User: Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories

Subsegments:
1) By Asparaginase: L-asparaginase, Erwinia Asparaginase, Pegylated Asparaginase
2) By Lipase: Gastric Lipase, Pancreatic Lipase, Fungal Lipase, Bacterial Lipase
3) By Protease: Serine Proteases, Cysteine Proteases, Aspartic Proteases, Metalloproteases
4) By Nattokinase: Nattokinase Powder, Nattokinase Capsules
5) By Chitinase: Plant Chitinase, Microbial Chitinase
6) By Serratiopeptidase: Serratiopeptidase Tablets, Serratiopeptidase Capsules
7) By Collagenase: Type I Collagenase, Type II Collagenase, Type III Collagenase
8) By Ligase: DNA Ligase, RNA Ligase
9) By Other Products: Amylase, Cellulase, Beta-Glucanase, Other Specialty Enzymes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3425&type=smp

Which Top Companies are Driving Growth in the Enzymes Market?
Major companies operating in the enzymes market include Novozymes A/S, DuPont Industrial Biosciences, BASF SE, Koninklijke DSM N.V., Chr. Hansen Holding A/S, Roche Holding AG, Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Codexis Inc., Dyadic International Inc., Amano Enzyme Inc., Adisseo France SAS, Biocatalysts Ltd., Amano Enzyme Inc., Enzyme Development Corporation, Creative Enzymes, Hayashibara Co. Ltd., Thermo Fisher Scientific Inc., Associated British Foods Plc, Lonza Group AG, Novus International Inc., Epygen Biotech, DSM Nutritional Products AG, Soufflet Biotechnologies SAS, Beijing Leili Marine Bioindustry Inc., Jiangsu Boli Bioproducts Co. Ltd.

Which Regions Will Dominate the Enzymes Market Through 2029?
North America was the largest region in the enzymes market in 2024. The regions covered in the enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3425

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.